Ignite Creation Date:
2024-05-05 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00154648
Status:
UNKNOWN
Last Update Posted:
2007-06-05
First Post:
2005-09-08
Brief Title:
CE-MRA Using Gadovist in Comparison to IA DSA Using Ultravist
Sponsor:
National Taiwan University Hospital
Organization:
National Taiwan University Hospital
Study Overview
Official Title:
An Open Contrast-Enhanced Magnetic Resonance Angiography CE-MRA Study of Arteries Using Gadovist 10 in Comparison to Intra-Arterial Digital Subtraction Angiography IA DSA Using Ultravist
Status:
UNKNOWN
Status Verified Date:
2005-06
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial is to show the diagnostic efficacy of Gadovist for contrast enhanced magnetic resonance angiography CE-MRA of the arteries
Detailed Description:
This trial is to show the diagnostic efficacy of Gadovist for contrast enhanced Magnetic Resonance Angiography CE-MRA of arteries specified vessel segments by analyzing the rate of agreement image quality and diagnostic confidence between a CE-MRA based diagnosis and the diagnosis achieved from the comparator procedure IA DSA using Ultravist
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None